A new virus fusion research team (CEVI fusion research team) led by the Korea Institute of Chemical Research has found antibodies against the new coronavirus (Covid-19), Yonhap reported today.
The top of the picture is the spike protein structure of the new coronavirus, and the left and right sides are the spike protein structures of SARS and the Middle East Respiratory Syndrome (MERS) respectively (source: courtesy of the Korea Chemical Research Institute)
The research team said that the spike protein structure of the new coronavirus is very similar to the structure of the spike protein of the Middle East Respiratory Syndrome (MERS) and SARS, and it has been confirmed that the latter can bind to its neutralizing antibody.
The research team analyzed the structural information file of the novel coronavirus spike protein disclosed on the bioscience preprint website "bioRxiv" and predicted that the two SARS neutralizing antibodies and the Middle East respiratory syndrome neutralizing antibody could interact with the novel The combination of coronavirus spike proteins is expected to contribute to vaccine development.
The results of the above study were published on bioRxiv on February 27. The research team also obtained a new coronavirus strain from the Department of Disease Management on February 17 and successfully obtained ribonucleic acid (RNA).
Special Report: Fighting The New Coronavirus
